Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 17/8/2017
SIETES contiene 91969 citas

 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]
2. Cita con resumen
Driessen JHM, de Vries F, van Onzenoort H, Harvey NC, Neef C, van den Bergh JPW, Vestergaard P, Henry RMA. The use of incretins and fractures – A meta-analysis on population-based real life data. Br J Clin Pharmacol 2017;83:923-6. [Ref.ID 101971]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Stolk LM, de Vries F, Ebbelaar C, de Boer A, Schalekamp T, Souverein P, ten Cate-Hoek A, Burden AM. Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. Br J Clin Pharmacol 2017;83:agosto. [Ref.ID 101480]
4. Cita con resumen
Nielen JTH, Dagnelie PC, Emans PJ, Veldhorst-Janssen N, Lalmohamed A, Van Staa T-P, Boonen AERCH, van den Bemt BJF, de Vries F. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements. Pharmacoepidemiol Drug Saf 2016;25:1245-52. [Ref.ID 100896]
5. Cita con resumen
van Dalem J, Brouwers MCGJ, Stehouwer CDA, Krings A, Leufkens HGM, Driessen JHM, de Vries F, Burden AM. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study. BMJ 2016;354:i3625. [Ref.ID 100570]
6.Enlace a cita original
Nielen JTH, de Vries F, Dagnelie PC, van den Bemt BJF, Emans PJ, Lalmohamed A, de Boer A, Boonen A. Use of thiazolidinediones and the risk of elective hip or knee replacement: a population based case–control study. Br J Clin Pharmacol 2016;81:370-8. [Ref.ID 100098]
7.Enlace a cita original
Goossens ME, Buntinx F, Zeegers MP, Driessen JHM, De Bruin ML, de Vries F. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol 2015;80:1464-72. [Ref.ID 99779]
8. Cita con resumen
Khong TP, de Vries F, Goldenberg JSB, Klungel OH, Ronbison NJ, Ibáñez L, Petri H. Potential impact of benzodiazepine use on the rate of hip fractures in five large European Countries and the United States. Calcif Tissue Int 2013;91:24-31. [Ref.ID 94615]
9. Cita con resumen
Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Voer A, Leufkens HGM, van Staa TP, de Vries F. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement. A nationwide cohort study. Arch Intern Med 2012;172:1229-35. [Ref.ID 94317]
10. Cita con resumen
de Vries F. Bisphosphonates and cancer. One database, many answers. BMJ 2010;341:905. [Ref.ID 89578]
11.Enlace a cita original
de Vries F, Setakis E, van Staa TP. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol 2010;70:429-38. [Ref.ID 89323]
12.Tiene citas relacionadas Cita con resumen
de Vries F, de Vries C, Cooper C, Leufkens B, van Staa TP. Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol 2006;35:1301-8. [Ref.ID 84294]
13.Tiene citas relacionadas Cita con resumen
van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C. Use of statins and risk of fractures. JAMA 2001;285:1850-5. [Ref.ID 55895]
Seleccionar todas
 1 a 13 de 13